Nuvalent (NUVL) Common Equity (2020 - 2026)
Nuvalent's Common Equity was $1.17 billion in Q1 2026, up 16.2% from $1.01 billion a year earlier but down 5.9% from the prior quarter.
Powered by 
Analysis
Nuvalent (NUVL) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Nuvalent came in at $1.25 billion, up 16.7% from FY2024.
- Common Equity has now increased for four consecutive years.
- In earlier years, Common Equity was $1.07 billion in FY2024 (+52.7%), $700.56 million in FY2023 (+51.3%), $462.98 million in FY2022 (+62.4%) and $285.04 million in FY2021.
- Quarterly Common Equity has moved between -$47.74 million (Q2 2021) and $1.25 billion (Q4 2025) over five years.
- Compared with a year earlier, Common Equity was higher in seven of the last eight quarters, with growth averaging 49.1%.
- The best year-over-year quarter for Common Equity over five years was Q3 2024 (growth of 183.1%); the worst was Q3 2025 (a decline of 24.6%).
- Per Business Quant data, NUVL's Common Equity in the three quarters before Q1 2026 was $1.25 billion (Q4 2025), $845.4 million (Q3 2025) and $939.74 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 1.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 845.40 Mn |
| Jun 30, 2025 | 939.74 Mn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 637.04 Mn |
| Mar 31, 2024 | 675.04 Mn |
| Dec 31, 2023 | 700.56 Mn |
| Sep 30, 2023 | 395.98 Mn |
| Jun 30, 2023 | 421.15 Mn |
| Mar 31, 2023 | 443.97 Mn |
| Dec 31, 2022 | 462.98 Mn |
| Sep 30, 2022 | 236.58 Mn |
| Jun 30, 2022 | 252.99 Mn |
| Mar 31, 2022 | 268.92 Mn |
| Dec 31, 2021 | 285.04 Mn |
| Sep 30, 2021 | 301.13 Mn |
| Jun 30, 2021 | -47.74 Mn |
API Access
Nuvalent Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NUVL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NUVL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NUVL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();